Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on December 6, 2013, regarding an event that occurred on December 5, 2013. The filing discloses the entry into a material definitive agreement concerning the adoption of a new equity incentive plan for non-employee directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity plan administration rather than financial performance.
Material Changes
The primary material change is the Board of Directors' approval and adoption of the 2013 Non-Employee Director Equity Incentive Plan. Key features include:
- Eligibility: Restricted to non-employee directors.
- Award Types: Options, stock appreciation rights, stock awards, restricted share units, or other stock-based awards.
- Share Reserve: An initial aggregate of 570,000 shares of common stock is authorized for issuance under the plan.
- Administration: Managed by the Compensation Committee, which holds authority to amend, suspend, or terminate the plan.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. Regarding contingencies and risks, the plan includes specific provisions for a Change of Control, allowing the Compensation Committee to accelerate vesting, cancel awards for fair value, issue substitute awards, or make options fully exercisable prior to the event.
Investor Verification Checklist
- Verify the full text of the 2013 Non-Employee Director Equity Incentive Plan filed as Exhibit 10.1.
- Confirm the total number of shares authorized (570,000) and how they interact with existing equity plans.
- Review the Compensation Committee's specific authority regarding plan amendments and termination.
- Understand the specific change of control provisions and their impact on director compensation.